FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel compounds of formula
,
where values A, R1-R6 are given in i.1 of the invention formula. Methods of obtaining the formula (I) compound are described.
EFFECT: compounds demonstrate an inhibiting activity of the cathepsin enzyme, which makes it possible to use them for the preparation of a pharmaceutical composition and for the preparation of a medication.
38 cl, 12 dwg, 495 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL CYCLOPENTANE DERIVATIVES | 2010 |
|
RU2572555C2 |
| NEW AZETIDINE DERIVATIVES | 2013 |
|
RU2629114C2 |
| NOVEL PYRROLIDINE DERIVATIVES | 2017 |
|
RU2736498C1 |
| PYRROLIDINE DERIVATIVES APPLICABLE AS CATEPSIN DERIVATIVES | 2011 |
|
RU2548684C2 |
| DERIVATIVES OF SULFONYLPYRROLIDINE | 2001 |
|
RU2272026C2 |
| SUBSTITUTED PYRROLIDIN-2-CARBOXAMIDE | 2011 |
|
RU2564022C2 |
| QUINAZOLINONES AS PROLYL HYDROXYLASE INHIBITORS | 2010 |
|
RU2528412C2 |
| PROCESS FOR PREPARATION OF 1-ACYL-4-PHENYLSULFONYLPROLINAMIDE DERIVATIVES AND NEW INTERMEDIATES | 2012 |
|
RU2615997C2 |
| CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF | 2020 |
|
RU2825000C2 |
| DERIVATIVES OF 6-AMINO QUINAZOLINE OR 3-CYANOQUINOLINE, METHODS OF THEIR PRODUCTION AND THEIR APPLICATION AS INHIBITORS OF RECEPTOR TYROZINE KINASES EGFR OR HER-2 | 2010 |
|
RU2536102C2 |
